Order number: 34CA.1
Part number: AC100008934
Crafted to support technical production environments, the HPLC Column Nucleodur® C 18 Pyramid offers a unique combination of features designed for optimal performance. With a particle size of 5 μm and a column volume of 0.35 ml, it ensures efficient separation while maintaining high pressure stability up to 600 bar. Its fully porous particles (FPP) and specific surface area of 340 m²/g provide ample interaction sites for hydrophobic and polar interactions (H bonds), making it ideal for separating very polar compounds such as pharmaceutical raw materials, organic acids, and penicillin antibiotics. The column's temperature stability of 60°C and compatibility with a wide pH range of 1.0-9.0 further expand its versatility. This analytical separation column comes packaged with an instruction leaflet and certificate
| Name | Value | |
|---|---|---|
| Phase | : | C 18 Pyramid |
| Endcapped | : | yes |
| Pore size | : | 110 Å |
| Column type | : | HPLC column |
| Pore volume | : | 0.9 ml/g |
| USP listing | : | L1 |
| Column shape | : | Analytical separation column |
| pH stability | : | 1,0-9,0 |
| Column volume | : | 0.35 ml |
| Particle size | : | 5 µm |
| Particle type | : | Fully porous particles (FPP) |
| Similar phases | : | Aqua ® Synergi™ Hydro-RP AQ Atlantis ® dC 18 Polaris ® C18-A |
| Eluent in column | : | Acetonitrile - Water |
| Surface chemistry | : | Octadecyl (C 18 , ODS) modification, Polar endcapping |
| Pressure stability | : | 600 bar |
| Separation principle | : | Reversed phase (RP) |
| Temperature stability | : | 60 ° C |
| L x Ø internal (column) | : | 50 x 3 mm |
| Recommended application(s) | : | Pharmaceutical raw materials Very polar compounds Analgesics Suitable for 100 % aqueous eluents Water-soluble vitamins Complexing agents Nucleic acid bases Organic acids Penicillin antibiotics |
| Specific surface according to BET | : | 340 m²/g |
| Interactions / retention mechanism | : | hydrophobic and polar (H bonds) |
© 2026 Copyright. All Rights Reserved.
© 2026 Copyright. All Rights Reserved.